Comments
Prevnar trial results needed for CDC recommendation
23.02.2012. | (Reuters) - Advisors to the U.S. Centers for Disease Control and Prevention on Wednesday will wait for results from a trial of Pfizer Inc's Prevnar 13 pneumonia vaccine before deciding whether to recommend its use in all adults aged 50 and older....
